Literature DB >> 33845003

Classification Criteria for Birdshot Chorioretinitis.

.   

Abstract

PURPOSE: To determine classification criteria for birdshot chorioretinitis.
DESIGN: Machine learning of cases with birdshot chorioretinitis and 8 other posterior uveitides.
METHODS: Cases of posterior uveitides were collected in an informatics-designed preliminary database, and a final database was constructed of cases achieving supermajority agreement on diagnosis, using formal consensus techniques. Cases were split into a training set and a validation set. Machine learning using multinomial logistic regression was used on the training set to determine a parsimonious set of criteria that minimized the misclassification rate among the infectious posterior uveitides / panuveitides. The resulting criteria were evaluated on the validation set.
RESULTS: One thousand sixty-eight cases of posterior uveitides, including 207 cases of birdshot chorioretinitis, were evaluated by machine learning. Key criteria for birdshot chorioretinitis included a multifocal choroiditis with (1) the characteristic appearance of a bilateral multifocal choroiditis with cream-colored or yellow-orange, oval or round choroidal spots ("birdshot" spots); (2) absent to mild anterior chamber inflammation; and (3) absent to moderate vitreous inflammation; or multifocal choroiditis with positive HLA-A29 testing and either classic "birdshot spots" or characteristic imaging on indocyanine green angiography. Overall accuracy for posterior uveitides was 93.9% in the training set and 98.0% (95% confidence interval 94.3, 99.3) in the validation set. The misclassification rates for birdshot chorioretinitis were 10% in the training set and 0% in the validation set.
CONCLUSIONS: The criteria for birdshot chorioretinitis had a low misclassification rate and seemed to perform sufficiently well for use in clinical and translational research.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 33845003      PMCID: PMC8517033          DOI: 10.1016/j.ajo.2021.03.059

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.488


  40 in total

1.  Sarcoid choroiditis simulating birdshot chorioretinopathy.

Authors:  Rahul N Khurana; Jignesh G Parikh; Narsing A Rao
Journal:  Retin Cases Brief Rep       Date:  2008

2.  Restoration of retinal architecture following systemic immunosuppression in birdshot chorioretinopathy.

Authors:  Farzin Forooghian; Nishi Gulati; Douglas A Jabs
Journal:  Ocul Immunol Inflamm       Date:  2010-08-25       Impact factor: 3.070

3.  Birdshot retinochoroidopathy masquerading as intraocular lymphoma.

Authors:  Elisabetta Miserocchi; Giulio Modorati; Umberto De Benedetto; Annalisa Colucci; Francesco Bandello
Journal:  Ocul Immunol Inflamm       Date:  2012-05-17       Impact factor: 3.070

4.  Spontaneous retinopathy in HLA-A29 transgenic mice.

Authors:  Y Szpak; J C Vieville; T Tabary; M C Naud; M Chopin; C Edelson; J H Cohen; J Dausset; Y de Kozak; M Pla
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

5.  Association of birdshot retinochoroidopathy and HLA-A29 antigen.

Authors:  G S Baarsma; H A Priem; A Kijlstra
Journal:  Curr Eye Res       Date:  1990       Impact factor: 2.424

6.  Loss of visual field among patients with birdshot chorioretinopathy.

Authors:  Jennifer E Thorne; Douglas A Jabs; Sanjay R Kedhar; George B Peters; James P Dunn
Journal:  Am J Ophthalmol       Date:  2007-11-12       Impact factor: 5.258

7.  Birdshot retinochoroidopathy associated with HLA-A29 antigen and immune responsiveness to retinal S-antigen.

Authors:  R B Nussenblatt; K K Mittal; S Ryan; W R Green; A E Maumenee
Journal:  Am J Ophthalmol       Date:  1982-08       Impact factor: 5.258

8.  Vitiliginous chorioretinitis.

Authors:  J D Gass
Journal:  Arch Ophthalmol       Date:  1981-10

9.  Contrast sensitivity among patients with birdshot chorioretinopathy.

Authors:  Peter J Kappel; Dominique Monnet; Fei Yu; Antoine P Brezin; Ralph D Levinson; Gary N Holland
Journal:  Am J Ophthalmol       Date:  2008-10-29       Impact factor: 5.258

Review 10.  Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop.

Authors:  Douglas A Jabs; Robert B Nussenblatt; James T Rosenbaum
Journal:  Am J Ophthalmol       Date:  2005-09       Impact factor: 5.258

View more
  6 in total

1.  Electrophysiological Assessment in Birdshot Chorioretinopathy: Flicker Electroretinograms Recorded With a Handheld Device.

Authors:  Anna M Waldie; Angharad E Hobby; Isabelle Chow; Elisa E Cornish; Mathura Indusegaran; Aleksandra Pekacka; Phuc Nguyen; Clare Fraser; Alison M Binns; Miles R Stanford; Christopher J Hammond; Peter J McCluskey; John R Grigg; Omar A Mahroo
Journal:  Transl Vis Sci Technol       Date:  2022-05-02       Impact factor: 3.048

Review 2.  A Comprehensive Update on Retinal Vasculitis: Etiologies, Manifestations and Treatments.

Authors:  Aniruddha Agarwal; Anne Rübsam; Lynn Zur Bonsen; Francesco Pichi; Piergiorgio Neri; Uwe Pleyer
Journal:  J Clin Med       Date:  2022-04-30       Impact factor: 4.964

3.  Observing the initial onset of retinal vasculitis as unilateral Birdshot Retinochoroiditis becomes bilateral: A case report.

Authors:  Natalie Huang; Isaac Kim; Bryan Rutledge; Dale D Hunter; Robert T Swan
Journal:  Am J Ophthalmol Case Rep       Date:  2022-05-23

4.  Development of Classification Criteria for the Uveitides.

Authors: 
Journal:  Am J Ophthalmol       Date:  2021-04-20       Impact factor: 5.488

Review 5.  [Development of classification criteria for uveitis by the standardization of uveitis nomenclature (SUN) working group].

Authors:  Arnd Heiligenhaus; Kai Rothaus; Uwe Pleyer
Journal:  Ophthalmologe       Date:  2021-08-30       Impact factor: 1.059

Review 6.  Birdshot Chorioretinopathy: A Review.

Authors:  Elodie Bousquet; Pierre Duraffour; Louis Debillon; Swathi Somisetty; Dominique Monnet; Antoine P Brézin
Journal:  J Clin Med       Date:  2022-08-16       Impact factor: 4.964

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.